We are pleased to announce that the deadline for abstract submission for ATTD 2016 has been extended.
If you have not yet submitted your abstract there is still time to share your latest research and contribute to the future of the field.
Why should I submit an abstract?
- ATTD is an unparalleled opportunity to present your work on today’s most cutting-edge topics connected to diabetes-related technology
- ATTD is a unique platform for the exchange of views on current issues with your professional peers and the distinguished international speakers
- All accepted abstracts are published in the peer-reviewed journal Diabetes Technology & Therapeutics, published by Mary Ann Liebert, Inc., Publishers
Take a leading role by submitting your abstract now!
Extended Submission Deadline: 21 October, 2015